Five-year agreement covers SBT Resolver sequencing-based product line and Assign analysis software.

Genomic HLA typing product firm Olerup SSP inked an exclusive five-year global marketing, sales, and distribution agreement with Australia-based Conexio for the latter’s SBT Resolver™-HLA sequencing-based typing (SBT) product line and a version of its Assign™ sequence analysis software. The firms have in addition agreed to co-develop new HLA typing products.

“This is a big step for us, and we expect the collaboration with Conexio to broaden and strengthen our position on the global HLA typing market with a very competitive SBT solution that complements our current product portfolio,” remarks CEO Olle Olerup, Ph.D.

Conexio’s SBT Resolver products are locus-specific PCR-based HLA sequencing reagents. Olerup claims the potential market for the SBT technology could match that of its own SSP business. In February the firm appointed Genese Produtos Diagnosticos as the distributor for its SSP HLA genotyping products in Brazil. Olerup claims Brazil represents the world’s second largest transplantation market after the U.S., and the firm expects to launch its products in the country during 2011.

Previous articleOxford BioMedica Grants Partner Pfizer Diagnostic Rights to 5T4 Tumor Antigen
Next articleInVivo and Miami Project to Combine Bioscaffolds with Schwann Cells for Spinal Cord Injury